Synapse - Find an Expert

5608 Results

Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology

Journal Article

Yankeelov, T. E.; Rooney, W. D.; Huang, W.; Dyke, J. P.; Li, X.; Tudorica, A.; Lee, J. H.; Koutcher, J. A.; Springer, C. S. Jr
NMR in Biomedicine (2005)

Fulltext@MSK | Save

Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome

Journal Article

Stephenson, A. J.; Bosl, G. J.; Motzer, R. J.; Kattan, M. W.; Stasi, J.; Bajorin, D. F.; Sheinfeld, J.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion

Journal Article

Stephenson, A. J.; Bosl, G. J.; Bajorin, D. F.; Stasi, J.; Motzer, R. J.; Sheinfeld, J.
Journal of Urology (2005)

Fulltext@MSK | Save

An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: Proof of principle

Journal Article

Spees, W. M.; Gade, T. P. F.; Yang, G.; Tong, W. P.; Bornmann, W. G.; Gorlick, R.; Koutcher, J. A.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma

Journal Article

Sorbellini, M.; Kattan, M. W.; Snyder, M. E.; Reuter, V.; Motzer, R.; Goetzl, M.; McKiernan, J.; Russo, P.
Journal of Urology (2005)

Fulltext@MSK | Save

Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel

Journal Article

Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy

Journal Article

Slovin, S. F.; Wilton, A. S.; Heller, G.; Scher, H. I.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

Journal Article

Slovin, S. F.; Ragupathi, G.; Musselli, C.; Fernandez, C.; Diani, M.; Verbel, D.; Danishefsky, S.; Livingston, P.; Scher, H. I.
Cancer Immunology, Immunotherapy (2005)

Fulltext@MSK | Save

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: A study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 or QS-21